Lab gears up to support COVID-19 trials

By Jenni Spinner contact

- Last updated on GMT

(Haydar Dogramaci/iStock via Getty Images Plus)
(Haydar Dogramaci/iStock via Getty Images Plus)

Related tags: Clinical trials, Laboratory, COVID-19, Coronavirus

Researchers at ACM Global Laboratories are focused on aiding clinical trials working on treatments for the deadly virus behind the current pandemic.

ACM Global Laboratories, a Rochester, NY company specializing in clinical trial testing services, currently supports studies in more than 65 countries around the world. Now, the company reports it has put in place specialized resources to better support clients conducting research on COVID-19 vaccines, treatments and other solutions.

ACM reportedly is boosting pandemic-related studies by offering special discounts and accelerated review process for COVID-19-centric studies.

We at ACM Global Laboratories have the tools, ability and desire to make a difference​,” said ACM chief commercial officer Thomas Mueller. “COVID-19 is affecting our communities and all who live in them. We are not only committed to using our resources to help defeat the virus but giving our communities the easiest and fastest means to do so, by prioritizing COVID-19 studies​.”

A company representative told Outsourcing-Pharma its resources include “MD- and PhD-level​” scientific and laboratory experts available to advise clients, as well as project managers, data management, quantitative expertise and other professionals. Additionally, its study support structure can customized sample and patient collection kits, dedicated project management, expert study set up, timely data reporting and integration, global logistics solutions and specimen management expertise and storage options.

The ACM team is available to conduct immunophenotypic analysis, support routine safety and bioanalytical study needs, coordinate and safely handle SARS CoV-2 PCR and serological antibody testing and provide guidance on vaccine assessment. It also offers state-of-the-art instruments and testing platforms, which are available to facilitate viral detection and perform assays to evaluate the safety and efficacy of vaccines and therapeutic interventions to treat COVID-19.

ACM Global Laboratories’ extraordinary teams immediately responded to the need for support for COVID-19 clinical trials as the company has for nearly 25 years​,” said ACM president Brian Wright. “When a global crisis happens, effective industry leaders like ACM don’t hesitate to be part of the solution and take actionable steps to mitigate the problem​."

ACM is currently supporting a number of ongoing COVID-19 clinical studies underway plans to offer its support services to additional trials in the future.

Related news

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Related suppliers

Follow us

Products

View more

Webinars